These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25850769)

  • 21. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis.
    Krokidis MG
    Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of amyotrophic lateral sclerosis.
    Corcia P; Couratier P; Blasco H; Andres CR; Beltran S; Meininger V; Vourc'h P
    Rev Neurol (Paris); 2017 May; 173(5):254-262. PubMed ID: 28449881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen.
    Blauw HM; Veldink JH; van Es MA; van Vught PW; Saris CG; van der Zwaag B; Franke L; Burbach JP; Wokke JH; Ophoff RA; van den Berg LH
    Lancet Neurol; 2008 Apr; 7(4):319-26. PubMed ID: 18313986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissection of genetic factors associated with amyotrophic lateral sclerosis.
    Leblond CS; Kaneb HM; Dion PA; Rouleau GA
    Exp Neurol; 2014 Dec; 262 Pt B():91-101. PubMed ID: 24780888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.
    Morello G; Guarnaccia M; Spampinato AG; La Cognata V; D'Agata V; Cavallaro S
    Mol Neurobiol; 2018 Feb; 55(2):1299-1322. PubMed ID: 28120152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging targets and treatments in amyotrophic lateral sclerosis.
    Zinman L; Cudkowicz M
    Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
    Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
    Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis.
    Morahan JM; Yu B; Trent RJ; Pamphlett R
    Amyotroph Lateral Scler; 2009; 10(5-6):418-29. PubMed ID: 19922134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M; Kwiecinski H
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next Generation Sequencing and ALS: known genes, different phenotyphes.
    Campopiano R; Ryskalin L; Giardina E; Zampatti S; Busceti CL; Biagioni F; Ferese R; Storto M; Gambardella S; Fornai F
    Arch Ital Biol; 2017 Dec; 155(4):110-117. PubMed ID: 29405028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
    Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel miR-b2122 regulates several ALS-related RNA-binding proteins.
    Hawley ZCE; Campos-Melo D; Strong MJ
    Mol Brain; 2017 Oct; 10(1):46. PubMed ID: 28969660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.
    Moujalled D; White AR
    CNS Drugs; 2016 Mar; 30(3):227-43. PubMed ID: 26895253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications.
    Battaglia G; Bruno V
    Curr Opin Pharmacol; 2018 Feb; 38():65-71. PubMed ID: 29529498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients.
    Saris CG; Horvath S; van Vught PW; van Es MA; Blauw HM; Fuller TF; Langfelder P; DeYoung J; Wokke JH; Veldink JH; van den Berg LH; Ophoff RA
    BMC Genomics; 2009 Aug; 10():405. PubMed ID: 19712483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.
    Paratore S; Pezzino S; Cavallaro S
    Curr Genomics; 2012 Jun; 13(4):321-33. PubMed ID: 23204922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targets for neuroprotection.
    Przedborski S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():14-8. PubMed ID: 15512862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in protein disulfide isomerase are associated with sporadic amyotrophic lateral sclerosis in the Chinese Han population.
    Yang Q; Guo ZB
    Int J Neurosci; 2016; 126(7):607-11. PubMed ID: 26000911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.